InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-6.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Sinclair Andrew, Director. Director active across 3 companies, notably Adicet Bio, Inc.. In total, 10 disclosures have been published. Split: 3 buys · 0 sell. Total volume traded: €12.4m. History available since 8 December 2021. The latest transaction was disclosed on 11 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Sinclair Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
5,900 shares0Common StockSEC:0000950170-25-086135:0
3,991 shares0Common StockSEC:0001415889-25-016360:0
6,500 shares0Common StockSEC:0001415889-24-016311:0
5,900 shares0Common StockSEC:0000950170-24-070575:0
5,900 shares0Common StockSEC:0001209191-23-033955:0
1,314,127 shares@ US$55.0091.0% of flowCommon Stock, $0.001 par valueSEC:0001493152-22-018397:0
7,720,000 sharesCommon StockSEC:0000905718-22-000521:0
Canonical exit: 27 Jun 2022 (T+90)
287,471 shares@ US$13.204.7% of flowCommon Stock, $0.001 par valueSEC:0000905718-22-000178:0
500,000 shares@ US$14.007.69% mcap25.0% of flowCommon StockSEC:0000905718-21-001591:0
Canonical exit: 8 Mar 2022 (T+90)
500,000 shares@ US$14.00100.0% of flowCommon StockSEC:0000905718-21-001587:0
Canonical exit: 8 Mar 2022 (T+90)
10 of 10 declarations
About Sinclair Andrew
Sinclair Andrew is Administrateur and a declarant, and is listed as a director at Adicet Bio, Inc., Soleno Therapeutics INC, and Sierra Oncology, Inc. He has filed 10 forms in total, and across the 10 recent filings available, the buy and sell amounts are 12415200 and 68981875 respectively, with activity from 2021-12-10 to 2025-06-13.
